The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II study of canakinumab (CAN) or pembrolizumab (PEM) as monotherapy or in combination as neoadjuvant therapy in patients (Pts) with surgically resected (Stage IB-IIIA) non-small cell lung cancer (NSCLC): CANOPY-N.
 
Tony S. K. Mok
Employment - The Chinese University of Hong Kong
Leadership - AstraZeneca; Hutchison MediPharma; Sanomics Limited
Stock and Other Ownership Interests - Hutchison MediPharma; Sanomics Limited
Honoraria - ACEA Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Fishawack Facilitate; Hutchison MediPharma; Ignyta; Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; SFJ Pharmaceuticals Group; Takeda; Vertex
Consulting or Advisory Role - ACEA Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Cirina; Clovis Oncology; geneDecode; Hutchison MediPharma; Ignyta; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Oncogenex; Pfizer; Roche/Genentech; SFJ Pharmaceuticals Group; Vertex
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SFJ Pharmaceuticals Group (Inst); Xcovery (Inst)
 
Pilar Garrido Lopez
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Guardant Health; Janssen-Cilag; Lilly; MSD Oncology; Pfizer; Roche Pharma AG; Takeda
Speakers' Bureau - AstraZeneca; Gilead Sciences; MSD Oncology; Roche Pharma AG; Takeda
Research Funding - Guardant Health (Inst); Sysmex (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Edward S. Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Roche/Genentech; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Roche/Genentech; Takeda
Research Funding - Boehringer Ingelheim; Genentech/Roche; Ignyta; Merck
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Merck; Pfizer; Takeda
 
Cagatay Arslan
No Relationships to Disclose
 
Jean-Louis Pujol
No Relationships to Disclose
 
Yuanbo Song
Employment - Novartis
 
Cecile Blin
Employment - Novartis
 
Vanessa Rodrik-Outmezguine
Employment - Novartis
Leadership - Novartis
 
Bijoyesh Mookerjee
Employment - Novartis
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; Incyte; Novartis
 
Vanessa Q. Passos
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jay M. Lee
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Merck; Novartis
Research Funding - Merck
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche